(4-((2-Morpholinoethyl)carbamoyl)phenyl)boronic acid, 95.0%, 250mg

NONAETHYLENE GLYCOL MONODODECYL ETHER, 95%, 100g

Potassium (R)-oxirane-2-carboxylate, 95.0%, 1g

4-(Methylthio)benzeneboronic acid, 97.0%, 1g

2-(Carboxymethyl)-4-nitrobenzoic acid, 95.0%, 5g

1-(4-Trifluoromethyl-pyridin-2-yl)-piperazine, 97.0%, 1g

1,2,4-Trimethylcyclohexane (mixture of stereoisomers)>96.0%(GC)500mL

1,1-Dioxo-1H-1lambda*6*-benzo[d]isothiazol-3-ylamine, 95.0%, 25g

Ethyl 6-[3-(N,N-Dimethylamino)phenyl]-6-oxohexanoate, 97.0%, 1g

Methyl 3-methoxypyridine-2-carboxylate, 95.0%, 100mg

2-Ethyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride, 97.0%, 250mg

(5-Bromo-2-((4-methoxybenzyl)oxy)phenyl)(3,5-dimethoxyphenyl)methanone, 95+%, 2g

3-Fluoro-4-(trifluoromethoxy)benzaldehyde, 97.0%, 25g